JP2024512986A5 - - Google Patents
Info
- Publication number
- JP2024512986A5 JP2024512986A5 JP2023559766A JP2023559766A JP2024512986A5 JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5 JP 2023559766 A JP2023559766 A JP 2023559766A JP 2023559766 A JP2023559766 A JP 2023559766A JP 2024512986 A5 JP2024512986 A5 JP 2024512986A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring atoms
- group
- alkenyl
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163167915P | 2021-03-30 | 2021-03-30 | |
| EP21305405.9 | 2021-03-30 | ||
| EP21305405 | 2021-03-30 | ||
| US63/167,915 | 2021-03-30 | ||
| PCT/EP2022/058402 WO2022207699A1 (en) | 2021-03-30 | 2022-03-30 | Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512986A JP2024512986A (ja) | 2024-03-21 |
| JP2024512986A5 true JP2024512986A5 (cg-RX-API-DMAC10.html) | 2025-04-02 |
Family
ID=81580241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023559766A Pending JP2024512986A (ja) | 2021-03-30 | 2022-03-30 | 改良された物理化学的特性および薬理学的特性を有する酵素トリガー自己反応性リンカー |
Country Status (10)
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12605459B2 (en) | 2020-07-13 | 2026-04-21 | Regeneron Pharmaceuticals, Inc. | Protein-drug conjugates comprising camptothecin analogs and methods of use thereof |
| MX2024008640A (es) * | 2022-01-12 | 2024-07-24 | Regeneron Pharma | Analogos de camptotecina conjugados a un residuo de glutamina en una proteina y su uso. |
| AU2023231442B2 (en) * | 2022-03-11 | 2026-07-02 | Mablink Bioscience | Antibody-drug conjugates and their uses |
| JP2026504840A (ja) * | 2023-01-11 | 2026-02-10 | ジェンマブ エー/エス | リンカー、薬物リンカー、およびそれらの複合体、ならびにそれらを使用する方法 |
| WO2024222841A1 (zh) * | 2023-04-27 | 2024-10-31 | 石药集团巨石生物制药有限公司 | 一种抗体药物偶联物 |
| AU2024263367A1 (en) * | 2023-04-27 | 2025-11-13 | CSPC Megalith Biopharmaceutical Co., Ltd. | Antibody-drug conjugate |
| EP4512427A1 (en) | 2023-08-25 | 2025-02-26 | Mablink Bioscience | Antibody-drug conjugates based on molecular glue degraders and uses thereof |
| EP4534102A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
| EP4534101A1 (en) | 2023-10-02 | 2025-04-09 | Eli Lilly and Company | Antibody drug conjugate (adc) targeting nectin 4 and comprising an exatecan payload |
| FR3155708A1 (fr) * | 2023-11-27 | 2025-05-30 | Skymab Biotherapeutics | Conjugue anticorps-medicament et ses utilisations |
| FR3155709A1 (fr) * | 2023-11-27 | 2025-05-30 | Skymab Biotherapeutics | Conjugue anticorps-medicament et ses utilisations |
| EP4566631A1 (en) | 2023-12-06 | 2025-06-11 | Heidelberg Pharma Research GmbH | New antibody drug conjugate as well as methods of production and uses thereof |
| WO2025230926A1 (en) * | 2024-04-29 | 2025-11-06 | Obi Pharma, Inc. | Improved linker-payloads for antibody conjugation, pharmaceutical compositions and applications thereof |
| WO2026076215A1 (en) * | 2024-10-03 | 2026-04-09 | Solve Therapeutics, Inc. | Conjugates and uses thereof |
| WO2026085106A1 (en) * | 2024-10-15 | 2026-04-23 | Solve Therapeutics, Inc. | Conjugates and uses thereof |
| WO2026086855A1 (zh) * | 2024-10-25 | 2026-04-30 | 石药集团巨石生物制药有限公司 | 一种靶向cdcp1的抗体药物偶联物及其用途 |
| WO2026112064A1 (en) * | 2024-11-20 | 2026-05-28 | Solve Therapeutics, Inc. | Conjugates of anti-5t4 antibodies with drugs and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2775976B1 (fr) * | 1998-03-10 | 2000-06-02 | Fabre Pierre Dermo Cosmetique | Composition pharmaceutique ou cosmetique contenant un precurseur d'actif hydrolysable par la glucocerebrosidase |
| FR2960153B1 (fr) | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
| US20170014524A1 (en) * | 2015-07-15 | 2017-01-19 | The California Institute For Biomedical Research | Auristatin-antibody conjugates and uses thereof |
| CN107847605B (zh) | 2015-11-25 | 2021-12-24 | 乐高化学生物科学股份有限公司 | 包含分支接头的抗体-药物缀合物及其相关方法 |
| EP3700577A1 (en) * | 2017-10-23 | 2020-09-02 | Mablink Bioscience | Ligand-drug-conjugate comprising a single molecular weight polysarcosine |
-
2022
- 2022-03-30 MX MX2023011630A patent/MX2023011630A/es unknown
- 2022-03-30 US US18/285,175 patent/US20240216525A1/en active Pending
- 2022-03-30 EP EP22720929.3A patent/EP4313157A1/en active Pending
- 2022-03-30 JP JP2023559766A patent/JP2024512986A/ja active Pending
- 2022-03-30 WO PCT/EP2022/058402 patent/WO2022207699A1/en not_active Ceased
- 2022-03-30 AU AU2022248565A patent/AU2022248565A1/en active Pending
- 2022-03-30 KR KR1020237037385A patent/KR20230165288A/ko active Pending
- 2022-03-30 BR BR112023019495A patent/BR112023019495A2/pt unknown
- 2022-03-30 IL IL306050A patent/IL306050A/en unknown
- 2022-03-30 CA CA3215279A patent/CA3215279A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7644173B2 (ja) | 単一分子量ポリサルコシンを含むリガンド-薬物-複合体 | |
| IL306050A (en) | Enzyme-triggered self-reacting linker having improved physicochemical and pharmacological properties | |
| JP2024042054A (ja) | カンプトテシンペプチドコンジュゲート | |
| JP2024099041A5 (cg-RX-API-DMAC10.html) | ||
| DK2678037T3 (en) | Branched linker for protein pharmaceutical conjugates | |
| JP2023529415A (ja) | 高安定性の親水性結合ユニットを有するカンプトテシン類薬物及びその複合体 | |
| JP2023514275A (ja) | 標的化された送達の用途のための線維芽細胞活性化タンパク質リガンド | |
| JP7814303B2 (ja) | 内部移行した生物学的に活性な化合物の結合体からの選択的な薬物放出 | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| JP2023530128A (ja) | 細胞結合分子とカンプトテシン類縁体との共役体 | |
| JP2021510696A5 (cg-RX-API-DMAC10.html) | ||
| JP2021527040A (ja) | カンプトテシンコンジュゲート | |
| JP2019502650A5 (ja) | 抗ErbB2抗体−薬物コンジュゲート及びその組成物、そのための調製方法、並びにその使用 | |
| JP2011102329A (ja) | ヘテロ二官能性重合体生物複合体 | |
| JP7750837B2 (ja) | 反応性コンジュゲート | |
| JP2023010733A (ja) | γ-アマニチンの誘導体 | |
| JP2022126826A (ja) | ヘテロアリールスルホンをベースとするコンジュゲーションハンドル、これらの調製のための方法、および抗体薬物コンジュゲートの合成におけるこれらの使用 | |
| CN104884056A (zh) | 用于制备缀合物的化合物和方法 | |
| JP2017501128A (ja) | ヒドラジニル−ピロロ化合物及び複合体を生成するための方法 | |
| CN112839683A (zh) | 含有标记部-抗人抗体Fab片段复合物的药物组合物 | |
| JP2024529466A5 (cg-RX-API-DMAC10.html) | ||
| CN120957758A (zh) | 大环化合物及其制备方法和用途 | |
| JP6585650B2 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2023159139A (ja) | 新規な連結体及び生体分子と薬物との特異的共役におけるその使用 | |
| KR960701667A (ko) | 2작용기성 킬레이트제, 그 테크네튬 및 레늄 착물과 이들의 제조방법 및 이들 화합물을 함유하는 방사성 약물 |